In the United States, the FDA has not approved BPC-157 for any indication, and it cannot legally be sold as a dietary supplement or as a finished pharmaceutical product
Y.JainS.et al (2012)
[2] For a patient managing conditions like leaky gut syndrome, irritable bowel disease, or NSAID-induced gastric injury, oral capsule formulations may therefore be both effective and logistically simpler than injection
We envision that this new GSH probe will enable unprecedented opportunities to study GSH dynamics and transportation and revolutionize our understanding of the physiological and pathological roles of GSH in living cells
Apply a thin layer to clean, dry skin once or twice daily, or as instructed
In 2014, the US Food and Drug Administration (FDA) acknowledged a GRAS (Generally Recognised as Safe) notification for AOD 9604 as a food ingredient meaning the FDA raised no questions about the notifier's own safety conclusion